Ad copy

Clinical data shows that 67% of patients with A1C between 7.0 and 8.5 achieve measurable reduction when they address damaged endothelium — not just blood sugar. I've reviewed 3,400+ A1C panels in 21 years as an endocrinologist. When a patient's first reading comes back at 7.6, I already know what happens if they follow standard advice. "Just manage it with metformin." Three years later: A1C 8.3. Now we're talking second-line agents. I'm Dr. James Patel, endocrinologist specializing in diabetes complications and vascular metabolism. When my own A1C came back at 8.1, I refused to accept "let's escalate your metformin." A1C 7.4. "Start metformin, monitor twice a year." Two years later: 8.2. Now discussing GLP-1 agonists. A1C 7.8. "Keep taking your meds." Three years later: 9.1. Insulin recommended. They all ask: "Why didn't you tell me I could still reverse it?" Because most endocrinologists don't believe established A1C trajectories can regress. They've been trained to manage decline, not reverse it. But that's not what the research shows. March 14th, 2024. My A1C: 8.1. My colleague said, "James, you need to start a sulfonylurea on top of the metformin. This is moving in the wrong direction." I left his office knowing there had to be another way. Here's what most endocrinologists miss: elevated A1C isn't the disease. It's the symptom of a process that's been damaging your blood vessels and your insulin signaling simultaneously. The real problem is damaged endothelium that can no longer produce nitric oxide naturally. And damaged insulin receptors that can no longer respond to insulin the way they're supposed to. Both downstream of the same vascular and inflammatory cascade. Metformin improves insulin sensitivity at the cellular level. Sulfonylureas force your pancreas to produce more insulin. GLP-1 agonists slow gastric emptying and reduce appetite. But none of them address the endothelial damage that's making everything else harder to control. That's why A1C keeps climbing despite medication. You're managing the number, not healing the system. Without addressing the root cause, A1C trajectories in diabetic patients average a 0.3-0.5 point increase per year despite standard care. My 8.1 becomes 8.6-9.1 in three years. Then we're looking at insulin therapy — and starting insulin in Type 2 diabetes is rarely a step you walk back. But I'd seen pilot research on diabetic endothelial regeneration. Studies showing measurable A1C reduction when you restore the blood vessel's ability to produce nitric oxide continuously — improving insulin signaling at the cellular level as a byproduct. Not just slowing. Actually reversing. The mechanism is called TRPV1 receptor activation. These are switches inside your blood vessels that trigger continuous nitric oxide production and endothelial healing. Most treatments give your endothelium temporary nitric oxide boosts that fade within hours. TRPV1 activation restores your vessel's ability to produce nitric oxide 24/7 — which has a direct downstream effect on cellular glucose uptake. That's the difference between managing diabetes and addressing what's causing the dysfunction in the first place. I'd seen clinical data on capsaicin — the compound in cayenne pepper — activating these TRPV1 receptors and improving insulin sensitivity and endothelial function simultaneously in diabetic patients. March 15th. I ordered pharmaceutical-grade capsaicin softgels. 3mg capsaicin per serving from 30,000 HU cayenne pepper. The exact dose shown to activate TRPV1 receptors in the published research. This wasn't about masking my A1C with another medication. This was about restoring my vessels' and my cells' ability to function the way they were supposed to. I started March 16th. 3 softgels daily with meals. Alongside my existing metformin. April 9th — 24 days in. Fasting glucose dropped from 138 to 119. My vessels and insulin signaling were responding. June 18th — 94 days in. Follow-up A1C. March: 8.1.June: 6.7. A 17% reduction in 94 days. Without adding a single new medication. The endothelial function tests showed my vessels were producing nitric oxide naturally again. Insulin sensitivity testing showed measurable improvement. Inflammatory markers — hsCRP, IL-6 — all dropped meaningfully. My "needs second-line agents" trajectory hadn't just stabilized. It had reversed because I addressed the root cause that metformin alone couldn't touch. I showed Dr. Patterson both panels. "Your A1C decreased 1.4 points. That's not just slowing — that's reversal. Even with aggressive medication addition we rarely see this in 90 days." "I restored my vessels' and cellular signaling through TRPV1 activation. Not just adding another drug — addressing what was actually broken." "If this is reproducible, we need to change how we counsel patients with elevated A1C. We're telling them to manage progression when they could be reversing the underlying dysfunction." If your A1C is 7.0 to 9.0, you're NOT too late. Your doctor probably presented it like this: Manage it with medication and hope it doesn't get worse. But they didn't tell you the real problem: your endothelium can't produce nitric oxide properly anymore, your insulin receptors are damaged, and temporary medications don't restore either function. A1C progression is predictable when you only manage with medication. Scores increase 0.3-0.5 points annually. A1C 7.8 today = 8.4 in two years = 9.2+ in five years. You've crossed the line into insulin territory. Now you need exogenous insulin for the rest of your life. My March A1C: 8.1. Standard progression predicted June A1C: 8.2-8.3. My actual June A1C: 6.7. I didn't just slow progression. I reversed it by 1.4 points in three months. Because I stopped managing symptoms and started healing the dysfunction. Even established Type 2 diabetes can regress when you restore your vessels' natural ability to produce nitric oxide continuously through TRPV1 activation — and the insulin sensitivity gains follow downstream. The difference between A1C of 7.2 and 8.4 is progression speed, not reversibility. Higher A1Cs need more urgent endothelial healing. But the mechanism is the same: restore endothelial function permanently, and your cells start responding to insulin the way they're supposed to. Your current A1C isn't a life sentence. It's telling you how urgently you need to address the dysfunction. But "just manage with metformin" means watching the number climb while taking pills that only address one piece of a broken system. If you've been told to "manage" your A1C with standard care alone, you deserve to know what I know from reading 21 years of A1C panels. Standard medications manage blood sugar and lower it temporarily. They don't restore your vessels' ability to produce nitric oxide or your insulin receptors' ability to respond. That's why A1C keeps climbing despite perfect medication compliance. Your A1C is what it is NOW. It will be higher in two years if you only follow symptom-management protocol. Then you're discussing insulin instead of reversal. Ninety-four days. That's how long it took my A1C to drop 1.4 points. I'm not saying ignore your endocrinologist or stop your medications. I'm saying understand what standard care actually does. It manages blood sugar. It doesn't heal the endothelial damage or restore the insulin sensitivity that elevated A1C is actually measuring. A1Cs don't stay the same. They increase or decrease. Symptom management alone often means increase. But TRPV1 activation and endothelial healing means decrease is possible. Act now, your next A1C check shows reversal. Wait, it shows progression. I review A1C panels every day. And I chose to address the root cause — damaged vessels and cellular signaling — not just manage the number. Give your endothelium a chance to heal. Restore your vessels' natural function. Even with elevated A1C, regression is possible. Because the alternative is watching your A1C climb past 9.0 while taking the same metformin doses, then starting insulin, then never coming off it. Your A1C gave you a warning. Use it to heal the dysfunction, not just manage the number. — Dr. James Patel, MD, FACEEndocrinologist, 21 yearsBoard Certified in Endocrinology and Metabolism P.S. — The pharmaceutical-grade capsaicin I used is Aurivita Capsaicin Power. 240 softgels per bag, 80 servings. 3 softgels per serving with 3mg capsaicin from 30,000 HU cayenne pepper. Pre-dissolved in cold-pressed oil. With BioPerine for the 2000% absorption boost. With K2 to prevent calcium deposition during vascular repair. If your A1C is between 7.0 and 9.0: Get your baseline panel. Add Aurivita Capsaicin Power to your existing regimen for 12 weeks. Get follow-up A1C testing. Let your panel show you what's possible when you address endothelial dysfunction and insulin signaling — the root cause, not just the symptom. You can always go back to managing with metformin alone. But you can't go back in time if you wait and watch your A1C climb into insulin-dependent territory while the underlying damage gets worse. 50% off and free shipping at https://aurivita.co/products/cayenne-pepper-softgels